You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 8, August 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Alzheimer Disease
 •Cognitive Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuropsychological Prediction of Conversion to Alzheimer Disease in Patients With Mild Cognitive Impairment

Matthias H. Tabert, PhD; Jennifer J. Manly, PhD; Xinhua Liu, PhD; Gregory H. Pelton, MD; Sara Rosenblum, BS; Marni Jacobs, BA; Diana Zamora, BA; Madeleine Goodkind, BA; Karen Bell, MD; Yaakov Stern, PhD; D. P. Devanand, MD

Arch Gen Psychiatry. 2006;63:916-924.

Context  The likelihood of conversion to Alzheimer disease (AD) in mild cognitive impairment (MCI) and the "optimal" early markers of conversion need to be established.

Objectives  To evaluate conversion rates to AD in subtypes of MCI and to identify neuropsychological measures most predictive of the time to conversion.

Design  Patients were followed up semiannually and controls annually. Subtypes of MCI were determined by using demographically adjusted regression norms on neuropsychological tests. Survival analysis was used to identify the most predictive neuropsychological measures.

Setting  Memory disorders clinic.

Participants  One hundred forty-eight patients reporting memory problems and 63 group-matched controls.

Main Outcome Measure  A consensus diagnosis of probable AD.

Results  At baseline, 108 patients met criteria for amnestic MCI: 87 had memory plus other cognitive domain deficits and 21 had pure memory deficits. The mean duration of follow-up for the 148 patients was 46.6 ± 24.6 months. In 3 years, 32 (50.0%) of 64 amnestic-"plus" and 2 (10.0%) of 20 "pure" amnestic patients converted to AD (P = .001). In 148 patients, of 5 a priori predictors, the percent savings from immediate to delayed recall on the Selective Reminding Test and the Wechsler Adult Intelligence Scale–Revised Digit Symbol Test were the strongest predictors of time to conversion. From the entire neuropsychological test battery, a stepwise selection procedure retained 2 measures in the final model: total immediate recall on the Selective Reminding Test (odds ratio per 1-point decrease, 1.10; 95% confidence interval, 1.05-1.14; P<.0001) and Digit Symbol Test coding (odds ratio, 1.06; 95% confidence interval, 1.01-1.11; P = .01). The combined predictive accuracy of these 2 measures for conversion by 3 years was 86%.

Conclusions  Mild cognitively impaired patients with memory plus other cognitive domain deficits, rather than those with pure amnestic MCI, constituted the high-risk group. Deficits in verbal memory and psychomotor speed/executive function abilities strongly predicted conversion to AD.


Author Affiliations: Department of Biological Psychiatry, New York State Psychiatric Institute (Drs Tabert, Pelton, and Devanand and Mss Rosenblum, Jacobs, Zamora, and Goodkind), Departments of Psychiatry (Drs Tabert, Pelton, Stern, and Devanand) and Neurology (Drs Manly, Pelton, Bell, Stern, and Devanand), and the Gertrude H. Sergievsky Center (Drs Tabert, Manly, Pelton, Bell, Stern, and Devanand), Columbia University College of Physicians and Surgeons, and Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Drs Tabert, Manly, Pelton, Bell, Stern, and Devanand) and Department of Biostatistics, Mailman School of Public Health (Dr Liu), Columbia University, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive Impairment in Older Adults Without Dementia: Clinical and Pathologic Outcomes in a Community-Based Sample
Wang et al.
J Geriatr Psychiatry Neurol 2009;22:256-265.
ABSTRACT  

Hormone therapy and cognitive function
Maki and Sundermann
Hum Reprod Update 2009;15:667-681.
ABSTRACT | FULL TEXT  

Linking Hippocampal Structure and Function to Memory Performance in an Aging Population
Reitz et al.
Arch Neurol 2009;66:1385-1392.
ABSTRACT | FULL TEXT  

Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study
Triebel et al.
Neurology 2009;73:928-934.
ABSTRACT | FULL TEXT  

Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
Farias et al.
Arch Neurol 2009;66:1151-1157.
ABSTRACT | FULL TEXT  

Donepezil delays progression to AD in MCI subjects with depressive symptoms
Lu et al.
Neurology 2009;72:2115-2121.
ABSTRACT | FULL TEXT  

The Importance of Alzheimer Disease Assessment Scale-cognitive Part in Predicting Progress for Amnestic Mild Cognitive Impairment to Alzheimer Disease
Rozzini et al.
J Geriatr Psychiatry Neurol 2008;21:261-267.
ABSTRACT  

Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients
Bombois et al.
Stroke 2008;39:2046-2051.
ABSTRACT | FULL TEXT  

Clinical referral patterns and cognitive profile in mild cognitive impairment
Lonie et al.
Br. J. Psychiatry 2008;192:59-64.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Characteristic Profiles of Instrumental Activities of Daily Living in Chinese Older Persons with Mild Cognitive Impairment
Woon Chi Tam et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:211-217.
ABSTRACT  

Aspirin and cognitive function
Whalley and Mowat
BMJ 2007;334:961-962.
FULL TEXT  

Evaluation of Cognitive Impairment in Older Adults: Combining Brief Informant and Performance Measures
Galvin et al.
Arch Neurol 2007;64:718-724.
ABSTRACT | FULL TEXT  

Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand et al.
Neurology 2007;68:828-836.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.